Completed NA INTERVENTIONAL 2-arm NCT04537819

Study of Imupret Application in the Technology of Delayed Prescription of Antibiotics in Patients With Acute Tonsillitis

A Multicenter, Randomized, Open, Comparative Study of Efficacy, Safety and Tolerability of Imupret Application in the Concept of Delayed Prescription of Antibiotics in Children, Aged 6-12 With Acute Tonsillitis

Sponsor: Bionorica SE

Conditions Acute Tonsillitis

Interventions Imupret in addition to local NAID Local NAID (Benzydamin)

Updated 5 times since 2020 Last updated: Aug 31, 2020 Started: Mar 20, 2019 Primary completion: Jan 20, 2020 Completion: Mar 25, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Acute Tonsillitis, this trial is completed. The trial is conducted by Bionorica SE and has accumulated 5 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bionorica SE
Ivano-Frankivsk National Medical University

Data source: Ivano-Frankivsk National Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ivano-Frankivsk, Ukraine